Paradigm Biopharmaceuticals Ltd.ASX: PAR

PAR reports pain reduction in oa patients

Sep 25, 2018 at 2:49 AM UTC · Issued by Paradigm Biopharmaceuticals Ltd.

Paradigm Biopharmaceuticals Ltd has released a press release.

View Attachment